[1] 曹毛毛, 李贺, 孙殿钦, 等. 2000—2019年中国胃癌流行病学趋势分析[J]. 中华消化外科杂志, 2021, 20(1): 102-109. [2] SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [3] 张瑞, 雷林, 彭绩, 等. 胃癌筛查的研究进展[J]. 中国肿瘤, 2020, 29(6): 411-418. [4] GILLEN S. Advancing early gastric cancer detection[J]. FEBS Open Bio, 2021, 11(7): 1812-1813. [5] EL ABIAD R, GERKE H. Gastric cancer: endoscopic diagnosis and staging[J]. Surg Oncol Clin N Am, 2012, 21(1): 1-19. [6] DAN Y Y, SO J B Y, YEOH K G. Endoscopic screening for gastric cancer[J]. Clin Gastroenterol Hepatol, 2006, 4(6): 709-716. [7] ZHAO Y J, JU Q, LI G C. Tumor markers for hepatocellular carcinoma[J]. Mol Clin Oncol, 2013, 1(4): 593-598. [8] LECH G, SLOTWINSKI R, KRASNODEBSKI I W. The role of tumor markers and biomarkers in colorectal cancer[J]. Neoplasma, 2014, 61(1): 1-8. [9] WANG Z, TIAN Y P. Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma[J]. Mol Clin Oncol, 2014, 2(2): 265-268. [10] HUANG Z B, ZHOU X, XU J, et al. Prognostic value of preoperative serum tumor markers in gastric cancer[J]. World J Clin Oncol, 2014, 5(2): 170-176. [11] JING J X, XU X Q, DU L L, et al. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer[J]. Int J Biol Markers, 2013, 28(2): 192-200. [12] HE B, ZHANG H Q, XIONG S P, et al. Changing patterns of serum CEA and CA199 for evaluating the response to first-line chemotherapy in patients with advanced gastric adenocarcinoma [J]. Asian Pac J Cancer Prev, 2015, 16(8): 3111-3116. [13] SINGH R, MISHRA M K, AGGARWAL H. Inflammation, immunity, and cancer[J]. Mediators Inflamm, 2017, 2017: 6027305. [14] WANG J, LIU Y Q, MI X G, et al. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics[J]. Ann Palliat Med, 2020, 9(3): 967-978. [15] FANG T Y, WANG Y M, YIN X, et al. Diagnostic sensitivity of NLR and PLR in early diagnosis of gastric cancer[J]. J Immunol Res, 2020, 2020: 9146042. [16] YIN X, FANG T Y, WANG Y M, et al. Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer[J]. Cancer Med, 2021, 10(3): 1103-1119. [17] VAN DAM P J, DAELEMANS S, ROSS E, et al. Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy[J]. Semin Cancer Biol, 2018, 52(Sup 2): 86-93. [18] YU J X, ZHENG W L. An alternative method for screening gastric cancer based on serum levels of CEA, CA19-9, and CA72-4[J]. J Gastrointest Canc, 2018, 49(1): 57-62. [19] SHIMADA H, NOIE T, OHASHI M, et al. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association[J]. Gastric Cancer, 2014, 17(1): 26-33. [20] ELINAV E, NOWARSKI R, THAISS C A, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms[J]. Nat Rev Cancer, 2013, 13(11): 759-771. [21] ATSUMI T, SINGH R, SABHARWAL L, et al. Inflammation amplifier, a new paradigm in cancer biology[J]. Cancer Res, 2014, 74(1): 8-14. [22] HIRSCHBERGER S, HINSKE L C, KRETH S. MiRNAs: dynamic regulators of immune cell functions in inflammation and cancer[J]. Cancer Lett, 2018, 431: 11-21. [23] OSTAN R, LANZARINI C, PINI E, et al. Inflammaging and cancer: a challenge for the Mediterranean diet[J]. Nutrients, 2015, 7(4): 2589-2621. [24] ZHANG X R, HU D, LIN X D, et al. Prognostic value of an inflammation-related index in 6, 865 Chinese patients with postoperative digestive tract cancers: the FIESTA study[J]. Front Oncol, 2019, 9: 427. [25] LI Z Y, LI S X, YING X J, et al. The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy[J]. Gastric Cancer, 2020, 23(3): 540-549. [26] IASONOS A, SCHRAG D, RAJ G V, et al. How to build and interpret a nomogram for cancer prognosis[J]. J Clin Oncol, 2008, 26(8): 1364-1370. |